Results. Estimates of positive predictive value of mammography by participants (n=71) were more accurate after using the aid than they guessed before using it, although that was partly due to confusion between different risk statistics presented in the decision aid. Twenty-one participants enrolled in the interview phase: twelve participated in an interview session within an hour of using Mammopad, and nine others were recalled weeks or months after first using Mammopad. Negative themes concerning numeric risk presentation were: 1) lack of gradations in perception of uncertainty based on numbers, 2) numbers are sometimes provided as explanation, instead of a tool for explaining, 3) skepticism about the value of numeric information in light of forgetting, and 4) confusion about different statistics. Positive themes were: 1) valuing grounding in real-world groups, 2) valuing a connection to medical research, and 3) valuing transparent enumeration of outcomes.
v Conclusions. The numerical risk graphics in Mammopad were well received and informative, although not memorable on a long-term basis. It may be helpful to administer Mammopad at multiple times during a patient's forties to refresh her memory. The more complicated of the two risk graphics in Mammopad was less often completely read or comprehended by participants, but cognitive tools such as animation could ease the cognitive burden of comprehending this information and improve understanding.
Introduction
A patient decision aid is an evidence-based tool designed to educate patients about their options concerning a specific medical decision--such as a choice between several treatments or screening options-as a supplement to, or preparation for clinical consultation. Because they focus on "preference-sensitive" 1 decisions-those where there is no "best" course of action across all patients-patient decision aids differ from general educational materials by helping patients understand how their own personal values relate to the features of the available decision options. 2 One of the touted benefits of decision aids is that that they allow more effective and balanced communication of risk information than occurs in typical clinical consultation. 3 Indeed, a 2014 Cochrane review found that across studies, patients who used patient decision aids in conjunction with typical care had superior knowledge and risk comprehension scores relative to patients who received care as usual. 4 The present study partnered with an existing research project that evaluated changes in decision quality measures reported by patients after using Mammopad, a mobile deviceoptimized patient decision aid. Mammopad was developed to encourage women in their forties to understand and consider the costs and benefits of breast cancer screening options, to clarify their own values in relation to those options, and to empower them to discuss screening mammography with their healthcare providers. Recently, recommendations for routine mammography screening have been called into question in the face of equivocal evidence of benefit, e.g. from randomized trials investigating the impact of routine mammography on breast cancer mortality for average-risk women in their forties. [5] [6] [7] Indeed, while some organizations maintain these recommendations, the United States Preventive Services Task Force (USPSTF) recommendations to recommends against routine screening mammography for women in their forties, stating that the decision to begin biennial mammography screening before age fifty "should be an individual one and take into account patient context, including the patient's values regarding specific benefits and harms." 8 In other words, the USPSTF has found the decision to undertake biennial mammography as a preference-sensitive decision for women in their forties.
This finding is supported by researchers with expertise in patient-centered care. 9, 10 The details of how to communicate risk to patients within a decision aid must be carefully considered on a case-by-case basis. There are many nontrivial decisions to make in creating a risk message. Currently, risk communication is as much an art as a science, despite a growing literature that maps the effects of risk formats [11] [12] [13] [14] [15] [16] , viewer characteristics [17] [18] [19] , and chart types [20] [21] [22] on outcomes such as perception of risk levels, gist or exact recall of risk statistics, and subsequent decision outcomes (i.e., application of risk knowledge). This mixedmethods study aimed to record the impressions and reaction of rural patients, in their own words, to quantitative risk information, to gain understanding of the role and perceived importance that risk information presented in a decision aid has in the medical decision-making experience. Simultaneously, I aimed to investigate the effectiveness of Mammopad's specific risk communication graphics, by probing recall of key statistics and success at answering a word problem that required application of the presented risk information. I deliberately did not include any multiple choice tests, as is common in risk studies, because recognition memory is different from recall, and I considered recall more relevant to the goal of evaluating risk knowledge about the decision at hand. 
Methods

I evaluated risk communication in
Participant Recruitment and Consent
Risk Scenario Participants
Participants in the Mammopad parent study, who were all women in their forties who were at average risk of breast cancer, were asked to answer the risk scenario question (described below in Section 2.3.1) immediately before and after using Mammopad. The parent study's participants were identified and recruited through chart review of three clinics identified through the Oregon Rural Practice-based Research Network (ORPRN) combined with telephone-based eligibility screening phone calls. They were screened to ensure that they were at average risk for breast cancer before they were permitted to proceed to using Mammopad.
The precise details of recruitment and participant flow into the parent before-after study, including the risk screening process, were reported previously. 
Interview Participants
Early interview participants were a convenience subsample of Mammopad participants.
After it was determined that all of these initial interviewees had previously had mammograms, the recruitment strategy was shifted to purposively recruiting Mammopad participants who had never had a mammogram. Because by this time the Mammopad study was also completing enrollment, this meant recalling some women who had participated previously. All interview participants were recruited in the following manner: they were offered the opportunity to participate in a 30-40 minute interview evaluating the Mammopad app in exchange for a gift card.
Consent
Participants consented separately for the parent Mammopad study and the semistructured interview. Both consent forms and study protocols were approved by the Oregon
Health & Science University Institutional Review Board in protocol IRB00007118.
Mammopad App
The Mammopad app included three main modules: an informational module on breast cancer, an informational module on mammography, and an interactive values assessment and clarification module. 23 Following completion of all modules of the app, a summary report was generated automatically and presented to participants; the report was then emailed to them if they provided a valid email address.
Data collection 2.3.1. Risk Scenario Phase
One risk scenario question was integrated seamlessly with the Mammopad decision aid to assess the participants' perception of the breast cancer risk associated with an abnormal mammogram result. This risk scenario question was posed to each participant immediately before using the decision aid. It read:
Jane is a woman in her 40s who is at average risk of developing breast cancer sometime during her life. She decides to have a mammogram to screen for breast cancer. She gets a call from her doctor saying that the result of the mammogram was abnormal and that she needs to have more tests to determine if she has breast cancer.
On a scale of 0 to 100, what are the chances that Jane has breast cancer, where 0 means she does not have breast cancer and 100 means she does have breast cancer.
The participant typed her response using the iPad's on-screen keypad. Immediately following the use of Mammopad, the question was again posed to the participant, and the response was collected in the same manner.
Interview Phase
An After the interview, I asked participants to answer a short questionnaire evaluating their objective numeracy skill using the 3-minute Berlin Numeracy Test 24, 25 Interviews with all participants were audio-recorded, with verbal consent being obtained for recording. Interviews were transcribed by paid transcriptionists, and I reviewed all transcripts for accuracy.
Analysis Methods
Risk Scenario Phase
Descriptive and inductive statistics were completed using IBM SPSS Statistics 22 (IBM Corporation, Somers, NY, USA). A Wilcoxon signed-rank significance test was planned to evaluate significance of change in risk estimates between pre-and post-Mammopad use.
Interview Phase
The semi-structured interviews were analyzed using a grounded theory approach.
Analysis was completed using nVivo, version 10 for Mac (QSR International Pty Ltd, Doncaster Victoria, Australia).
Early Coding
One primary coder (myself) and two secondary coders contributed to the qualitative
analysis. An initial review of three transcripts was undertaken by two coders using an open coding framework, which allowed analysts to add new codes at any time in the analysis. The coders then met to go over transcript coding and consensually converge on an initial coding scheme. The initial scheme included two levels, nodes and (optionally) subnodes. The coding scheme, with the option for adding new codes, was used to code the remaining transcripts, with each transcript being coded by the primary coder and one secondary coder, and with review sessions resulting in consensus coding of each transcript recorded in nVivo software. These review sessions were held after every two to three transcripts coded. After each review session, the coding schema was updated and redistributed.
Refined coding
Following the consensus coding of all transcripts, the analytic team independently critiqued the codes and came to consensus about refinements to the coding scheme from a topdown perspective. Then, for each code in the schema, the primary coder and one secondary coder reviewed all references that had been coded and drafted recommendations regarding changes to the schema. The analytic team then met to share their independent reports on each code/theme and to jointly connect and organize codes/themes, resulting in a final list of themes.
Finally, quotes were selected to illustrate these themes.
Results
Demographic characteristics of the participants in the risk scenario phase and the interview phase are presented in Table 1 .
Berlin numeracy score was assessed for the interview participants. One participant was not administered the Berlin Numeracy Test due to experimenter error. Possible scores ranged from 0 to 4 with no partial credit awarded. The sample mean score was 1.8 (sd=1.15).
Individual characteristics of participants in the interview phase are provided in Appendix III.
Risk scenario Phase
Non-numeric responses were converted to numeric responses when there was no ambiguity; for example, "Fifty-fifty" was converted to 50, and "twenty percent" was converted to 20. Six of the 75 participants responded to either or both the pretest and posttest with a nonnumeric response that could not be directly translated to a single number and were excluded from further analysis. Thus, 69 response pairs were included in the experiment analysis. After using the decision aid, the participants reduced their ratings of how likely it was that Jane had cancer given an abnormal screening mammogram. This change was in the direction of a more accurate response. Based on the risk graphic presented in the decision aid, the target answer was 2.0 or 3.0, depending on whether or not the instance of "pre-cancer" was considered to be an instance of cancer. Before using Mammopad, participants gave a median response of 50, whereas the response after using Mammopad had a median of 6 (see Table 2 ).
By a Wilcoxon signed-rank test, this was a statistically significant reduction; Z(69) = 5.721, p < .001; there were 49 negative shifts, 4 positive shifts, and 16 ties.
Interview Phase
Twenty-one of the Mammopad participants also participated in the interview.
Enrollment for this portion of the study began toward the end of enrollment in the parent study.
Early-enrolled participants in this study had their interview sessions immediately following the Mammopad session. Because the study team was short of the goal of enrolling 20 participants by the time the parent study concluded enrollment, later-enrolled interview participants returned for the interview weeks or even months after their initial sessions. Thus, I have gathered both immediate and delayed impressions of the decision aid.
Themes on numeric risk presentation
Several themes were expressed by participants about how they perceived the importance of quantitative risk information, both in Mammopad and generally. In describing them, I coarsely divide these into negative and positive themes.
Negative Theme 1: Lack of gradations in perception of uncertainty based on numbers
Some participants expressed a dislike of quantitative risk information in a manner that suggested they did not translate risk numbers into internal gradations of risk. For these women, uncertainty seemed unquantifiable, as illustrated by the following quotations. Knowing that the participant could only be referring to the risk scenario question discussed earlier in this paper (as no questions were posed about the incidence statistics), her statement indicates that she was trying to deduce the likelihood that our hypothetical patient, Jane, had cancer, from the cancer incidence statistics and not from the mammography outcomes data. To be sure, it is unclear whether this confusion was due to misinterpretation of the question itself, or to incomplete comprehension or forgetting of the data in the mammography outcomes flow chart. After manually examining the individual responses to the risk scenario question across the larger subject pool, however, I found potential evidence that other participants were similarly confused.
Mammopad presented breast cancer incidence for average-risk women in their forties as being 1 in 70. This is equivalent to 1.4%. Participants who tried to use the incidence rate to answer the risk scenario question would have rounded this down and given a response of 1 in the risk scenario question. Indeed, 18 participants did answer 1 to this question-nearly as many as those who gave a correct answer of 2 or 3 (22) . Two others typed out "1 in 70", which we converted to a fraction and included in the analysis. This data provides additional evidence that participants had a tendency to confuse the breast cancer incidence risk with the risks derived from the mammography outcomes graphic.
Positive Theme 1: Valuing grounding in real-world groups.
A frequently-mentioned theme was that of grounding in real world groups. There is a concreteness about natural frequencies that does not exist in presenting abstract percentages or probabilities. One important element of the desire for grounding in real world groups seemed to be that it was important to be able to visualize the denominator group; for example, one 
Risk Graphics: Recall of Statistics and Participant Impressions
Participants were asked to discuss any numbers that they remembered reading in the Mammopad app. If they did not recall any specific numbers, they were probed as to what they thought the risk of breast cancer was for women in their forties. For twelve participants, the interview session occurred immediately after using the decision aid; although not explicitly timed, the duration of the delay between presentation and recall was estimated to be 15-30 minutes for these participants. The remaining nine participants returned to the clinic for the interview between 14 and 122 days (median = 114, mean = 90) following the initial use of Mammopad.
Cancer Incidence Pictographs
Participants who were interviewed immediately after using the decision aid tended to recall at least some of the quantitative information from the cancer incidence pictograph. Of the 11 participants in this category who were asked the question i , seven met our criteria for perfect recall, in that they stated that the risk of breast cancer for women in their forties was 1 in 70 and that the risk for women in their fifties was 2 in 70 or double. Three participants recalled partial information, either that the incidence rate doubled between the forties and fifties or only the incidence rate for women in their forties. Finally, one participant could not recall any incidence rate from the app. Unsurprisingly, the nine participants who were interviewed between two i One participant who would be in this category was not probed specifically about the incidence statistics and could not be analyzed.
weeks and four months after using Mammopad displayed poorer recall of the incidence statistics. One participant recalled the frequency "1 in 70" but could not answer as to what the reference group was (i.e., women in their forties.) Four participants could not recall any numbers from the app. The remaining four participants recalled or guessed incorrectly; their four respective responses each exceeded the true incidence rate substantially: 1 in 7, 1 in 4, 35%, and 30%. From this small group, there is little evidence to support that participants recalled even the gist of the breast cancer incidence rates (1 in 70; about 1.4%) presented in the app after a delay of at least two weeks.
Participants responded positively to the cancer incidence pictographs (shown in Figure   1 ). Participants often brought up liking the pink color and finding the simple and I can see myself being a part of that group more than if it's not using a number at all, and maybe that's why it's helpful in that app to have the little people as part of, you know, the way you have the graphic there. (Participant #17) The use of woman-shaped icons in the pictograph, therefore, may have contributed to women feeling that the information they were learning was grounded in real-world groups that they themselves could be part of.
Mammography Outcomes Flow Chart
Only three participants voluntarily recalled any information from the mammography outcomes flow chart: one recalled nearly the entire figure verbatim, one recalled only that there was a denominator of 1000, and one recalled that there was just "just a very small amount" of abnormal tests that turned out to be cancer.
When reviewing the graphic during the interview, participants responded more variably to the mammography outcomes flow chart than to the risk incidence pictographs. Several participants stated that they had not read the entire flow chart when going through the app. The The participant seems to have followed one branch of the mammography outcomes flow chart, and never returned to the top of the flow chart to read the remaining branch. Another participant described a different process leading to incomplete reading of the flowchart diagram. After admitting that she had not noticed that one cancer was missed, she stated: It is true that there was some overlap in the content between the two pages, but most of the information in the flow chart was not provided in the previous page, which read only:
"Mammography isn't perfect. There are tradeoffs. In fact, for every 1000 women like you that have a mammogram we expect…" (compare with Figure 2 ).
Most participants liked having the information provided in this graphic, and considered it to be important. Participants described liking the bold lines and color scheme, but there were mixed reviews of the stick-figure representation of a woman having a mammogram that had been integrated into the screenshot: some participants thought it was cute or clever, while others actively disliked it, and one thought "it reminds me a little bit of hangman."(Participant #04). ii Although, as another participant pointed out, the actual areas that were ultimately used were misleading, from this perspective.
PARTICIPANT: Yeah. One out of a thousand.
This discussion suggests that in spite of having read and comprehended all the relevant frequency data about outcomes, the participant came to the false conclusion that mammography could rule out breast cancer.
Discussion and Conclusions
Discussion
This study aimed to characterize patients' comprehension, memory, and impressions of risk communication messages in a patient decision aid, Mammopad. After using Mammopad, participants tended to estimate that the positive predictive value of mammography (as measured by a risk scenario question) was significantly lower (median = 6%) than they guessed it to be before using the aid (median=50%). While the posttest estimate is much closer to the true value, this shift is probably partly attributable to confusion about different, related risks that were presented in Mammopad (incidence of breast cancer over 10 years vs. outcome of mammography on a specific day). Although unlikely to completely resolve confusion, I suggest two hypothetical alterations to the decision aid that may have mitigated this tendency for participants to distinct (but topically-related) risk enumerations: 1) including a discussion explicitly contrasting the differences between the reference classes in the mammography outcomes flow chart and the breast cancer incidence pictograph, or 2) including knowledge-test quiz questions after each of the breast cancer modules. Each of these has potential benefits and drawbacks. Further research would be needed to determine which, if either of these, would be most effective in reducing confusion.
Some of the themes that emerged from the qualitative interviews indicated a dubiousness or outright distrust of being told numerical risk estimates in medical contexts. The comments of some participants suggesting that they were insensitive to probability gradations is consistent with the results of a study by Rottenstreich and Hsee that found that the more emotionally entangled the context of a decision was, the less sensitive participants were to variations in statistics. 27 Indeed, medical situations and decisions are often quite affect-laden.
Another theme, a desire for doctors not to focus on the numbers too much, is not surprising if one subscribes to the prevalent, dual systems/processes models of decision making that suggest contributions by both a slow, logical component and a fast, affective or intuitive component. 28, 29 The risk scenario question results and recall results demonstrated that the Mammopad risk communication diagrams were reasonably effective in informing participants about true incidence of breast cancer and the outcomes of mammography, although the timeframe at which even gist memory of this information persists is disappointingly brief. This is of some concern because the type of medical decision being made, whether or not to be screened in one's forties, has an extended duration of up to a decade. Although some participants expressed doubt about the value of quantification of risk in light of propensity for forgetting, the thematic analysis suggests that some of the value of being presented with numbers is that it leads to trust being conferred upon the source. With this trust in place, participants may be more likely to at least remember their own decision on when to begin screening, even if they have forgotten all relevant risk statistics.
Participants generally liked the risk presentation graphics included in Mammopad. The breast cancer incidence pictographs were described by participants as easily comprehensible and visually appealing. The simplicity of these pictograph and the accompanying text, and the ease with which they could induce visualization of a real-world group of women (perhaps aided by the use of woman-shaped icons) seemed to contribute to the appeal of this particular set of graphics. The mammography outcomes flow chart graphic was more obtuse, and only some of the participants appeared to fully comprehend all the information it contained. Although there were some graphical design decisions that led to a subset of participants having mixed feelings about this graphic, other participants simply disliked the graphic because they deemed it too complicated or it took them too long to comprehend. In future versions of this decision aid or with similar risk communication graphics, the situation may be improved by further unpacking the information in this graphic into more of a narrative, as might be achieved through animation. Doing so may improve the comprehensibility of the data to people with limited graph literacy, although this would likely come at the expense of forcing all participants to explore the chart in either a depth-first or breadth-first manner, to the exclusion of their own preferences.
A strong aspect of this study was that patients with real screening decisions used
Mammopad in a clinic, just as they might before a provider appointment when making the final decision about when to begin screening mammograms. The study had some limitations, however. The recall portions of the study would have benefitted from a larger sample size so that a population estimate could be made for immediate and delayed recall of risk information presented in the decision aid. Because this study was tailored to mammography decisions, lessons learned from it may not transfer to contexts of treatment decisions or other screening decisions.
Conclusions
The numerical risk graphics in Mammopad were well received and informative, although not memorable on a long-term basis. It may be helpful to administer Mammopad at multiple times during a patient's forties to refresh her memory. The more complicated of the two risk graphics, the mammography outcome flow chart, was less often completely read or comprehended by participants, but further simplification seems imprudent considering how important the information provided in this graphic was considered by those who were able to comprehend it. Still, cognitive tools such as animation could ease the cognitive burden of comprehending this information and improve understanding.
What information or activities from the decision aid made the biggest impression on you? Can you tell me about anything that was hard to understand? What had value?
Can you tell me about any numbers or statistics in the decision aid that were either helpful or difficult to follow? Prompt: What would you say is the biggest risk factor of breast cancer?
Can you tell me about radiation from mammograms?
Numeracy
When a healthcare provider uses numbers in talking to you about your health, how does it make you feel?
 Prompt: What thoughts come to mind?  Prompt: Why do doctors or nurses use numbers to talk about risk?
Can you tell me about a time when information about risk or probability helped you make a health-related decision? Closing: Is there anything else you could tell me about, perhaps that I neglected to ask about?
